Gallagher Canada’s Post

Pharmacist Alert: FDA Update on Contraceptive Use with Mounjaro (Tirzepatide ) As a pharmacist, staying up-to-date with the latest drug safety information is crucial—especially when new precautions are introduced that can impact patient care. The FDA has recently issued updated guidance regarding the use of oral contraceptives in patients taking Mounjaro (tirzepatide). Although Mounjaro itself does not directly interact with oral contraceptives, the FDA is now recommending that patients consider alternative or dual methods of contraception when using this medication. This precaution is primarily due to the potential gastrointestinal side effects (e.g., nausea, vomiting, diarrhea) associated with Mounjaro, which may interfere with the absorption of oral contraceptives and reduce their effectiveness. Reference

⚠️ Important Update: The FDA has recently issued updated guidance regarding the use of oral contraceptives in patients taking Mounjaro (tirzepatide). 💊 Pharmacist Alert: Staying up-to-date with the latest drug safety information is crucial—especially when new precautions are introduced that can impact patient care. 🔗 Key Point: Although Mounjaro itself does not directly interact with oral contraceptives, the FDA is now recommending that patients consider alternative or dual methods of contraception when using this medication. 🚨 Why This Matters: This precaution is primarily due to the potential gastrointestinal side effects (e.g., nausea, vomiting, diarrhea) associated with Mounjaro, which may interfere with the absorption of oral contraceptives and reduce their effectiveness. 📚 Reference: FDA Guidance on Mounjaro and Contraceptive https://lnkd.in/dVYxWBdW --- Helpful? 🔁 Repost it to your network and follow for more valuable insights! Want to boost your social media presence and stay updated on the latest pharmacy and digital marketing trends? Join our community of 7000+ subscribers today: https://lnkd.in/dHC6FTMG

What advice should we give patients about oral contraceptives when on GLP1 agonists? Mounjaro's label has a warning about effectiveness of oral contraception during initiation and dose change. Our Clinical Effectiveness Unit (CEU) offers an enquiry service for FSRH members, providing summaries of the latest evidence and guidance on contraceptive use for women with specific medical conditions. In response to recent member enquiries about the impact of GLP-1 agonists like Semaglutide (Ozempic®) and Tirzepatide (Mounjaro®) on oral contraceptives, we would like to share our findings with you. Read our response: https://lnkd.in/e495Hs5v

GP Action: harness the opportunity We appreciate that it’s tougher than usual for community pharmacies during this period of industrial action by GPs. However, this provides contractors with an ideal opportunity to showcase how community pharmacy can deliver brilliant patient-centred care for everyone. You’re undoubtedly going to see even more people into your pharmacy, and this is your chance to communicate with both new and existing patients the wide array of services that community pharmacy can offer. Here are a few suggestions to ensure you and your team ✅ Brief your team – tell them what you would like them to say to new patients when they visit ✅ Inform female patients about the Contraception Service. Heading on holiday and can’t get your contraception from your GP practice? No problem, we can help and here’s how ✅ Offer patients a blood pressure test ✅ Ask every person who visits if they’d like to book a flu jab ✅ Take very opportunity to market your pharmacy and make sure everyone in your local community knows exactly what you can do when it comes to primary care Simply do your best for everyone you talk to over the coming weeks and months – let them know you’re always here to help. #communitypharmacy #pharmacy #pharmacist

Contracpetion for women with hypertension- DKT has you covered. Laktasi contracpetive daily oral pills is a safe and effective choice.

𝗗𝗮𝘁𝗲 𝗳𝗼𝗿 𝘆𝗼𝘂𝗿 𝗱𝗶𝗮𝗿𝘆: 𝗡𝗛𝗦 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝘆 𝗖𝗼𝗻𝘁𝗿𝗮𝗰𝗲𝗽𝘁𝗶𝗼𝗻 𝗦𝗲𝗿𝘃𝗶𝗰𝗲 (𝗣𝗖𝗦) - 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝗶𝗻𝗴 𝗵𝗶𝗴𝗵 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗰𝗼𝗻𝘀𝘂𝗹𝘁𝗮𝘁𝗶𝗼𝗻𝘀 𝗗𝗮𝘁𝗲 𝗮𝗻𝗱 𝘁𝗶𝗺𝗲: 𝗧𝘂𝗲𝘀𝗱𝗮𝘆 𝟰𝘁𝗵 𝗙𝗲𝗯𝗿𝘂𝗮𝗿𝘆 𝟮𝟬𝟮𝟱 𝗳𝗿𝗼𝗺 𝟳-𝟵𝗽𝗺 𝗟𝗼𝗰𝗮𝘁𝗶𝗼𝗻: 𝗞𝗲𝗴𝘄𝗼𝗿𝘁𝗵 𝗛𝗼𝘁𝗲𝗹 𝗮𝗻𝗱 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗖𝗲𝗻𝘁𝗿𝗲, 𝗣𝗮𝗰𝗸𝗶𝗻𝗴𝘁𝗼𝗻 𝗛𝗶𝗹𝗹, 𝗞𝗲𝗴𝘄𝗼𝗿𝘁𝗵, 𝗗𝗘𝟳𝟰 𝟮𝗗𝗙 CPPE, Community Pharmacy Derbyshire and Community Pharmacy Nottinghamshire have teamed up to host this collaborative workshop for contractors and their teams.   The Community Pharmacy England website reminds us that the 31st March 2025 is the deadline for pharmacy owners who are delivering Pharmacy First to also deliver the Pharmacy Contraception Service and Hypertension Case-Finding Service to qualify for the monthly £1,000 fixed payment (as well as meeting the relevant consultation threshold). This is a great opportunity for those who are not yet signed up to this service to get trained and signed up to the service by the end of March. 𝗧𝗵𝗶𝘀 𝗲𝘃𝗲𝗻𝘁 𝗶𝘀 𝗹𝗶𝗺𝗶𝘁𝗲𝗱 𝘁𝗼 𝟰𝟮 𝗽𝗹𝗮𝗰𝗲𝘀 𝘀𝗼 𝗲𝗮𝗿𝗹𝘆 𝗯𝗼𝗼𝗸𝗶𝗻𝗴 𝗶𝘀 𝗲𝘀𝘀𝗲𝗻𝘁𝗶𝗮𝗹.   Emma Anderson, Regional CPPE Tutor, says: "As well as working for CPPE, I am a jobbing community pharmacist, so I know how busy and pressured things are now. Therefore, we have designed the learning to make the most of the time that you have available. Preparation tasks are based on a self-assessment of your needs. Following the workshop there is an option to attend a support webinar with Kirsty Armstrong who leads the service for NHS England and Alastair Buxton of Community Pharmacy England. Two other community pharmacists and I who deliver the service will also be there to answer questions. The workshop part of this learning will be hosted by Penny Mosley, and I will be attending as speaker for the event". You can book the workshop here 👇🏻 https://lnkd.in/eu6hNA2N  You will also find a link to book the post workshop support webinar in that page. 𝗣𝗹𝗲𝗮𝘀𝗲 𝗻𝗼𝘁𝗲: 𝘆𝗼𝘂 𝘄𝗶𝗹𝗹 𝗻𝗲𝗲𝗱 𝗮 𝗸𝗲𝘆𝗰𝗼𝗱𝗲 𝗳𝗼𝗿 𝘁𝗵𝗶𝘀 𝗲𝘃𝗲𝗻𝘁 𝘀𝗼 𝗲𝗺𝗮𝗶𝗹 𝗳𝗿𝗼𝗺 𝘆𝗼𝘂𝗿 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝘆 𝗡𝗛𝗦 𝗺𝗮𝗶𝗹 𝘁𝗼 𝗶𝗻𝗳𝗼@𝗰𝗽𝗻𝗼𝘁𝘁𝘀.𝗼𝗿𝗴 𝗮𝗻𝗱 𝘁𝗵𝗶𝘀 𝘄𝗶𝗹𝗹 𝗯𝗲 𝗳𝗼𝗿𝘄𝗮𝗿𝗱𝗲𝗱 𝘁𝗼 𝘆𝗼𝘂. #pharmacyservices #pharmacycontraceptionservice #pharmacyfirst #training #workshop #communitypharmacy #pharmacists

𝗗𝗮𝘁𝗲 𝗳𝗼𝗿 𝘆𝗼𝘂𝗿 𝗱𝗶𝗮𝗿𝘆: 𝗡𝗛𝗦 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝘆 𝗖𝗼𝗻𝘁𝗿𝗮𝗰𝗲𝗽𝘁𝗶𝗼𝗻 𝗦𝗲𝗿𝘃𝗶𝗰𝗲 (𝗣𝗖𝗦) - 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝗶𝗻𝗴 𝗵𝗶𝗴𝗵 𝗾𝘂𝗮𝗹𝗶𝘁𝘆 𝗰𝗼𝗻𝘀𝘂𝗹𝘁𝗮𝘁𝗶𝗼𝗻𝘀 𝗗𝗮𝘁𝗲 𝗮𝗻𝗱 𝘁𝗶𝗺𝗲: 𝗧𝘂𝗲𝘀𝗱𝗮𝘆 𝟰𝘁𝗵 𝗙𝗲𝗯𝗿𝘂𝗮𝗿𝘆 𝟮𝟬𝟮𝟱 𝗳𝗿𝗼𝗺 𝟳-𝟵𝗽𝗺 𝗟𝗼𝗰𝗮𝘁𝗶𝗼𝗻: 𝗞𝗲𝗴𝘄𝗼𝗿𝘁𝗵 𝗛𝗼𝘁𝗲𝗹 𝗮𝗻𝗱 𝗖𝗼𝗻𝗳𝗲𝗿𝗲𝗻𝗰𝗲 𝗖𝗲𝗻𝘁𝗿𝗲, 𝗣𝗮𝗰𝗸𝗶𝗻𝗴𝘁𝗼𝗻 𝗛𝗶𝗹𝗹, 𝗞𝗲𝗴𝘄𝗼𝗿𝘁𝗵, 𝗗𝗘𝟳𝟰 𝟮𝗗𝗙 CPPE, Community Pharmacy Nottinghamshire and Community Pharmacy Derbyshire have teamed up to host this collaborative workshop for contractors and their teams.   The Community Pharmacy England website reminds us that the 31st March 2025 is the deadline for pharmacy owners who are delivering Pharmacy First to also deliver the Pharmacy Contraception Service and Hypertension Case-Finding Service to qualify for the monthly £1,000 fixed payment (as well as meeting the relevant consultation threshold). Mike Jones of Community Pharmacy Nottinghamshire comments: “We are excited to bring you this contraception learning opportunity. This is a great opportunity for those who are not yet signed up to this service. We are keen to get you trained and signed up to the service by the end of March 2025. 𝗧𝗵𝗶𝘀 𝗲𝘃𝗲𝗻𝘁 𝗶𝘀 𝗹𝗶𝗺𝗶𝘁𝗲𝗱 𝘁𝗼 𝟰𝟮 𝗽𝗹𝗮𝗰𝗲𝘀 𝘀𝗼 𝗲𝗮𝗿𝗹𝘆 𝗯𝗼𝗼𝗸𝗶𝗻𝗴 𝗶𝘀 𝗲𝘀𝘀𝗲𝗻𝘁𝗶𝗮𝗹."   Emma Anderson, Regional CPPE Tutor, says: "As well as working for CPPE, I am a jobbing community pharmacist, so I know how busy and pressured things are now. Therefore, we have designed the learning to make the most of the time that you have available. Preparation tasks are based on a self-assessment of your needs. Following the workshop there is an option to attend a support webinar with Kirsty Armstrong who leads the service for NHS England and Alastair Buxton of Community Pharmacy England. Two other community pharmacists and I who deliver the service will also be there to answer questions. The workshop part of this learning will be hosted by Penny Mosley, and I will be attending as speaker for the event". You can book the workshop here 👇🏻 https://lnkd.in/eu6hNA2N  You will also find a link to book the post workshop support webinar in that page. 𝗣𝗹𝗲𝗮𝘀𝗲 𝗻𝗼𝘁𝗲: 𝘆𝗼𝘂 𝘄𝗶𝗹𝗹 𝗻𝗲𝗲𝗱 𝗮 𝗸𝗲𝘆𝗰𝗼𝗱𝗲 𝗳𝗼𝗿 𝘁𝗵𝗶𝘀 𝗲𝘃𝗲𝗻𝘁 𝘀𝗼 𝗲𝗺𝗮𝗶𝗹 𝗳𝗿𝗼𝗺 𝘆𝗼𝘂𝗿 𝗽𝗵𝗮𝗿𝗺𝗮𝗰𝘆 𝗡𝗛𝗦 𝗺𝗮𝗶𝗹 𝘁𝗼 𝗶𝗻𝗳𝗼@𝗰𝗽𝗻𝗼𝘁𝘁𝘀.𝗼𝗿𝗴 𝗮𝗻𝗱 𝘁𝗵𝗶𝘀 𝘄𝗶𝗹𝗹 𝗯𝗲 𝗳𝗼𝗿𝘄𝗮𝗿𝗱𝗲𝗱 𝘁𝗼 𝘆𝗼𝘂. #pharmacyservices #pharmacycontraceptionservice #pharmacyfirst #training #workshop #communitypharmacy #pharmacists

The Biden-Harris administration has been busy working to promote #ContraceptiveAccess and quality. Today, the Centers for Medicaid and CHIP Services (CMCS) released a CMCS Information Bulletin (CIB) on “#Medicaid #FamilyPlanning Services and Supplies: Requirements and Best Practices.” This CIB provides states with guidance on requirements for the coverage of family planning services and supplies, strategies to reduce barriers and increase access to contraception, confidentiality protections for those seeking family planning services and supplies, and information on #QualityMeasures. https://lnkd.in/eeYAqKN4   Earlier this week, the Centers for Disease Control and Prevention (CDC) released U.S. Medical Eligibility Criteria for Contraceptive Use, 2024 (U.S. MEC) and U.S. Selected Practice Recommendations for Contraceptive Use, 2024 (U.S. SPR) (https://lnkd.in/ezw9S67i). These updated evidence-based #contraception recommendations can be used by health care providers to support the provision of person-centered contraceptive counseling and services in a non-coercive manner and remove unnecessary medical barriers to accessing and using contraception. Of note, the CDC Practice Recommendations includes exciting new guidance on pain management for IUD insertion, an issue Deanna Hartog, J.D. and I tackled in a blog post last summer. The guidance outlines that: 1. Providers should counsel patients about pain management before the IUD insertion procedure. 2. Pain management should be a “shared decision making” process—in other words, providers are being asked to focus more on a patient’s individual preferences and concerns 3. More pain relief options should be available during the procedure. In addition to lidocaine shots, people can now also request anesthetic gel, creams and sprays. View CDC’s updated contraceptive guidance: https://lnkd.in/e468F2TE View NHeLP's related blog post on raising the standard of care for #IUD-related pain management: https://lnkd.in/ebRV9SYU

In honor of Women's Health Month, we're highlighting pharmacists' pivotal role in supporting women. From providing counseling on contraception to managing menopause symptoms, you can equip women with the education and resources needed to maintain their health. Learn other ways you can make a difference. #pharmacy #pharmacist #pharmacistrole #womenshealth #SingleCare #womenshealthmonth

I'm thrilled to announce that I will present three posters at the upcoming ISPOR 2024 conference in Atlanta from May 8-10. 📊 I will present three posters "Comparative Cost-Effectiveness of Interventions for Perinatal Methamphetamine Use Disorder" - Exploring Transcranial magnetic stimulation (TMS) as a solution for Methamphetamine use disorders in pregnant women. "Barriers and Provision of Emergency and Pharmacist-Prescribed Contraception" - Highlighting crucial insights from pharmacy practices in Utah. "Risk of Gastrointestinal (GI) Bleeding for Aspirin Users" - A comprehensive review to predict the risk of GI bleeding with low-dose aspirin Looking forward to connecting with peers, exploring groundbreaking research, and contributing to our understanding of these critical issues. Let's make a difference together! 🚀 #ISPOR2024 #HealthEconomics #OutcomesResearch #PublicHealth #Pharmacotherapy